Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
<i>BRAF</i> Mutation in Colorectal Cancer: An Enigmatic TargetCathy Eng
The Lancet. Oncology|July 18, 2015
Circulating DNA biomarkers: a primer for metastatic colorectal cancer?Cathy Eng
Cancer Investigation|August 31, 2006
Anal cancer: current and future methodologyCathy Eng
Nature Reviews. Clinical Oncology|April 1, 2009
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancerCathy Eng
Surgical Oncology Clinics of North America|November 28, 2016
PrefaceCathy Eng
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Carcinoma of the anal canal: small steps in treatment advancesCathy Eng
Clinical Advances in Hematology & Oncology : H&O|April 9, 2008
K-Ras and sensitivity to EGFR inhibitors in metastatic colorectal cancerCathy Eng
The Oncologist|January 14, 2010
The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial developmentCathy Eng
The Lancet. Gastroenterology & Hepatology|April 14, 2017
POLE mutations in colorectal cancer: a new biomarker?Cathy Eng
Clinical Colorectal Cancer|December 6, 2007
Combining targeted therapies to enhance the effectiveness of chemotherapy in patients with treatment-refractory colorectal cancerCathy Eng
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
<i>BRAF</i> Mutation in Colorectal Cancer: An Enigmatic TargetCathy Eng
The Lancet. Oncology|July 18, 2015
Circulating DNA biomarkers: a primer for metastatic colorectal cancer?Cathy Eng
Cancer Investigation|August 31, 2006
Anal cancer: current and future methodologyCathy Eng
Nature Reviews. Clinical Oncology|April 1, 2009
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancerCathy Eng
Surgical Oncology Clinics of North America|November 28, 2016
PrefaceCathy Eng
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Carcinoma of the anal canal: small steps in treatment advancesCathy Eng
Clinical Advances in Hematology & Oncology : H&O|April 9, 2008
K-Ras and sensitivity to EGFR inhibitors in metastatic colorectal cancerCathy Eng
The Oncologist|January 14, 2010
The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial developmentCathy Eng
The Lancet. Gastroenterology & Hepatology|April 14, 2017
POLE mutations in colorectal cancer: a new biomarker?Cathy Eng
Clinical Colorectal Cancer|December 6, 2007
Combining targeted therapies to enhance the effectiveness of chemotherapy in patients with treatment-refractory colorectal cancerCathy Eng
Pageof 32